Melanoma Insights for Professionals

From collaboration to innovation: How multidisciplinary teams and clinical trials are transforming melanoma care

Redefining Immunotherapy (Ep. 5): Hype vs Reality: The Future of Immunotherapy

Redefining Immunotherapy (Ep. 4): Melanoma Treatment Strategy: Expert Perspectives

[Trailer] Redefining Immunotherapy (Ep. 4): Melanoma Treatment Strategy

Redefining Immunotherapy (Ep. 3): Immunotherapy Toxicity: Prevention, Early Recognition and Management to Optimise Outcome

Redefining Immunotherapy (Ep. 2): Predict, Treat, Monitor: The Quest for Smarter Immunotherapy Decisions

Redefining Immunotherapy (Ep. 1): Beyond the Tumour: Rethinking Cancer in the Immunotherapy Era

After the diagnosis: Getting follow-up care right in melanoma

Overdiagnosis or early detection? The controversy of melanoma in situ

Utilising melanoma risk prediction tools for newly diagnosed patients

Sentinel node biopsy in melanoma: Still recommended in 2025?

Integrating AI in melanoma care

The future of melanoma detection and management: Perspectives from world-leading clinicians

Unveiling melanoma research: Shaping the future with innovative research infrastructure

Transforming cancer care: Neoadjuvant therapy and trials in melanoma care

Current and emerging biomarkers for melanoma care

Spotlight on mucosal melanoma: Head and neck

Dealing with diagnostic uncertainty and borderline pathology

Melanoma: When do I scan?

When to recommend a sentinel node biopsy in melanoma

Neoadjuvant immunotherapy: Revolutionising melanoma treatment

Unravelling lentigo maligna

Diagnosis and management of uveal melanoma

Getting the pathology right: Melanoma in General Practice